Guidance, NICE advice and quality standards in development | Guidance

Showing 31 to 40 of 382

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]	Technology appraisal guidance	TBC
Avacincaptad pegol for treating geographic atrophy caused by age-related macular degeneration [ID6401]	Technology appraisal guidance	TBC
Avapritinib for treating moderate to severe indolent systemic mastocytosis [ID6578]	Technology appraisal guidance	26 August 2026
Avelumab for previously treated platinum-resistant ovarian cancer ID1497	Technology appraisal guidance	TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]	Technology appraisal guidance	TBC
Avelumab with axitinib for untreated advanced renal cell carcinoma (MA review of TA645) [ID6294]	Technology appraisal guidance	TBC
Beating heart mitral valve repair by artificial chordae insertion for mitral regurgitation	Interventional procedures guidance	4 March 2026
Bed frames for adults in medical or surgical hospital wards: Late Stage-assessment	Health technology evaluation	19 August 2025
Belantamab mafodotin for treating relapsed or refractory multiple myeloma after 4 or more therapies [ID2701]	Technology appraisal guidance	TBC
Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [ID6212]	Technology appraisal guidance	TBC